Latest Regulatory Compliance News

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.

Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.

ASX Limited has reported a robust first half of FY25 with record operating revenue and a near 10% rise in underlying net profit, underpinned by strong growth across key business segments and a strategic focus on technology modernization.

Gold Mountain Limited has confirmed high-grade Rare Earth Oxide mineralisation from 56 drill holes at its Down Under REE Project in Brazil, highlighting significant potential for resource expansion and further exploration.

ASX Limited reported a solid half-year performance for 1H25, with operating revenue up 5.9% to $541.9 million and an interim dividend increase to 111.2 cents per share. The company continues to invest heavily in technology upgrades while navigating ongoing regulatory scrutiny.

Pioneer Lithium has successfully raised $1.3 million in the first tranche of a $1.62 million placement, earmarked to accelerate its uranium project development. A second tranche awaits shareholder approval, signaling continued momentum for the company’s strategic growth.

The Commonwealth Bank of Australia has released its December 2024 Basel III Pillar 3 report, reaffirming strong capital adequacy and liquidity positions despite evolving regulatory frameworks.